Financial Summary (All financials)
| In millions, except per share items | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 |
| Revenues | 757.5 | 750.7 | 614.9 | 30.4 | | |
| Revenue growth | 0.9% | 22.1% | 1926.1% | | | |
| Cost of goods sold | 513.2 | 528.6 | 496.8 | 41.8 | | |
| Gross profit | 244.3 | 222.0 | 118.1 | -11.5 | | |
| Gross margin | 32.2% | 29.6% | 19.2% | -37.8% | | |
| Research and development | 1.9 | 11.6 | | | | |
| General and administrative | 19.7 | 66.2 | 73.4 | 22.9 | | |
| EBIT | 224.3 | -22.8 | 41.1 | -34.4 | | |
| EBIT margin | 29.6% | -3.0% | 6.7% | -113.2% | | |
| Pre-tax income | 177.5 | -55.9 | 23.3 | -39.7 | | |
| Income taxes | 2.5 | -0.8 | -1.4 | 0.0 | | |
| Tax rate | 1.4% | 1.3% | | 0.0% | | |
| Net income | 175.0 | 54.2 | 0.0 | 0.0 | | |
| Net margin | 23.1% | 7.2% | 0.0% | 0.0% | | |
| |
| Diluted EPS | | $0.39 | | | | |
| Shares outstanding (diluted) | | 139.0 | | | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|